Synthetic bone substitute heracure one

for orthopedic surgerymalleableputty

Product description
heracure one is designed to fill non-infected bone defects after trauma, reconstruction or corrective intervention. It is applied directly from the syringe into the bone defect and sets only after contact with aqueous liquids, requiring no preparation steps and allowing unlimited working time during application. The product is a calcium phosphate-based paste provided in prefilled syringes that self-sets in vivo to form a bone-like microcrystalline hydroxyapatite. Manufactured in Germany and MDR certified.

Key features

• Calcium phosphate-based paste in prefilled syringes
• Ready to use — no preparation steps necessary
• Self-setting in vivo (hardens after contact with aqueous liquids)
• Bone-like composition (forms microcrystalline hydroxyapatite)
• Proprietary manufacturing in Germany
• MDR certified

Advantages of heracure one

• Ready-to-Use: available in several syringe sizes to meet diverse clinical needs — immediately applicable without preparation and with no time pressure during surgery
• Easy handling and precise application: pasty, cohesive consistency that is easily injectable for controlled placement
• In vivo self-setting: hardens directly within the bone defect after contact with body fluids, ensuring adaptation to defect shape for stability and integration
• Bone-like composition: calcium phosphate converts to microcrystalline hydroxyapatite similar to natural bone, supporting biocompatibility
• Resorbability: resorbed via cell-mediated processes and gradually replaced by endogenous bone
• Versatile application: suitable for various bone defects, tumor resections and implant fixation
• Osteoconductive properties: facilitates bone cell attachment and supports natural bone regeneration
• Mechanical strength: reaches compressive strength up to 35 MPa within a few days

Available sizes

• 1 ml
• 3 ml
• 6 ml
• 12 ml

Indications

• Filling non-infected and non-load-bearing bone defects or defects sufficiently stabilized by suitable measures
• Metaphyseal bone defect fractures (e.g., tibia, radius, humerus)
• Bone defects following resection of benign tumors and cysts
• Bone defects after removal or replacement of osteosynthesis implants
• Support for fixation of osteosynthesis implants, including bone screws

Technical characteristics / specifications

• Composition: Calcium phosphate paste that converts to microcrystalline hydroxyapatite
• Presentation: Prefilled syringes, paste consistency, cohesive and injectable
• Sizes/Volumes: 1 ml, 3 ml, 6 ml, 12 ml
• Setting mechanism: In vivo self-setting after contact with aqueous liquids
• Working time: Unlimited working time during application (sets only after contact with aqueous liquids)
• Mechanical strength: Up to 35 MPa compressive strength within a few days
• Resorbability: Cell-mediated resorption with replacement by endogenous bone over time
• Intended use: Filling non-infected, non-load-bearing bone defects or stabilized defects
• Manufacturing: Proprietary manufacturing in Germany
• Regulatory: MDR certified